As of Aug 28
| -0.09 / -5.03%|
The 1 analysts offering 12-month price forecasts for X T L Biopharmaceuticals Ltd have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +252.94% increase from the last price of 1.70.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.